Time Schedule
Monday, April 09 19:30-20:30 Opening Ceremony | 20:30-21:00 Keynote Speaker | 21:00-21:30 Discussion | 22:00 Dinner | Tuesday, April 10 07:00-08:00 Breakfast / Registration | 1st Session: Acute Coronary Syndrome (ACS): 08:00-09:15 | 08:00-08:25 Acute Coronary Syndrome Management: Current Challenges and Emerging Solutions. | 08:25-08:50 Dug Eluting Stent: An Update on Clinical Data. | 08:50-09:05 Antiplatelet Strategies in Acute Coronary Syndrome: Expanding Choices. | 09:15-09:30 Discussion | 09:30-09:40 Break | 2nd Session: Evolution of Antithrombotic Therapy Use in Acute Coronary Syndrome: 09:40-10:45 | 9:40-10:05 Anticoagulant in ACS and Beyond. | 10:05-10:30 Newer Antiplatelet: Confronting the Limitations of Antiplatelet Therapy. | 10:30-10:55 Risk of Bleeding: Balancing Risk and Benefit. | 10:55-11:10 Discussion | 11:10-11:20 Break | 3rd Session: Heart Failure (HF): 11:20-12:15 | 11:20-11:45 Heart Failure: Current Medical Therapy. | 11:45-12:10 Heart Rate as a Therapeutic Target in Heart Failure Patients. | 12:10-12:35 Devices and Technology in the Management of Heart Failure. | 12:35-12:50 Discussion | 12:50-14:00 Prayer Time, Lunch Break, Exhibition | 4th Session: Hypertension: 14:00-16:00 | 14:00-14:25 Update on Hypertension Management. | 14:25-14:50 JNC 8 (VIII): What is new going to be in the guidelines? | 14:50-15:15 Strategies for the Management of Resistant Hypertension. | 15:15-15:30 Discussion, Prayer Time | 5th Session: Ambulatory care in Cardiology: 15:30-16:45 | 15:30-15:55 Medication safety concerns in the cardiovascular patient. | 15:55-16:20 Lipid management: Optimizing Therapies Old and New. | 16:20-16:45 Primary prevention of cardiovascular disease: Tools and Strategies. | 16:45-17:00 Discussion | Wednesday, April 11 07:00-08:00 Breakfast / Registration | 1st Session: Atrial fibrillation (Afib): 08:00-09:15 | 08:00-08:25 Contemporary approach in Atrial Fibrillation Management. | 08:25-08:50 Antithrombotic Therapy in Afib: Defining the future of Oral Anticoagulant Therapy. | 08:50-09:15 Combined Atrial Fibrillation and Heart Failure: Challenges in Pharmacotherapy Management. | 09:15-09:30 Discussion | 09:30-09:40 Break | 2nd Session: End stage Heart Failure and Heart Transplant: 09:30-10:45 | 09:40-10:05 ICU Management of End Stage Heart Failure and Mechanical Circulatory Support Therapy. | 10:05-10:30 Heart Transplant: indication, selection, pre and post op care. | 10:30-10:55 Long Term Management of Heart Transplant and the Pharmacist Role. | 10:55-11:10 Discussion | 11:10-11:20 Break | 3rd Session: Venous Thromboembolism (VTE) Challenge and Valvular Heart Disease (VHD) Management: 11:00-12:15 | 11:20-11:45 VTE: Acute and Chronic Management. | 11:45-12:10 Contemporary Management of VHD in Various Medical Settings. | 12:10-12:35 Transcatheter Aortic Valve Implantation (TAVI): Highlight on Procedural and Pharmacotherapy Management Implications. | 12:35-12:50 Discussion | 12:50-14:00 Prayer Time, Lunch Break, Exhibition | 4th Session: Personalized Medicine in Cardiology: 14:00-16:00 | 14:00-14:25 Antiplatelet resistant / un-responsiveness: Genomic Markers and Advanced Testing. | 14:25-14:50 Tailored antiplatelet therapy: Pharmacogenomics or Dynamic Applications? | 14:50-15:15 Women cardiology: Differences in Diagnosis and Management. | 15:15-15:30 Discussion, Prayer | 5th Session: Pulmonary Hypertension: 15:30-16:45 | 15:30-15:55 Diagnosis and Treatment of Pulmonary Hypertension. | 15:55-16:20 Pulmonary Hypertension in ICU Setting. | 16:20-16:45 Perspectives on Pharmacoeconomic Appropriateness of Pulmonary Hypertension Medications. | 16:45-17:00 Discussion | 17:00-17:30: Closing Ceremony
Slider

Medical Services General Directorate

Since its founding by His Majesty, the late King Abdul-Aziz, the Kingdom of Saudi Arabia has paid close attention to health care, which was a great motivation to continue the effort for the development of the health sector in the Kingdom in general, and in the armed forces in particular.

Since His Royal Highness, the Crown Prince, Minister of Defense and Aviation and Inspector General assumed the mission of the Ministry of Defense, efforts of development have continued at all levels.
This was evident by qualitative leaps achieved by the Medical Services General Directorate in the increase of health facilities that provide treatment for the children of the armed forces personnel and their dependents. Many large specialized hospitals and health centers have been established, equipped with state-of-the-art modern medical equipment and managed by very skillful Saudi personnel.

The organization of the Armed Forces in Saudi Arabia led to the establishment of the Army Medical Department in Taif city in 1367(AH), as a 10-bed clinic. However, in 1370 (AH), it was renamed Military Health, and in 1371 (AH), Prince Mansour Military Hospital in Taif was inaugurated with a capacity of 36 beds, which was eventually increased to 100 beds by the end of the year.

In 1373 (AH), Prince Meshal Hospital in Al-Kharj was inaugurated, followed in the same year by the inauguration of the Armed Forces Hospital in Riyadh.

On 29/12/1392 (AH), an executive decree by His Royal Highness, the Crown Prince and Minister of Defense and Aviation and Inspector General was issued to amend the title into the “Armed Forces Medical Services General Directorate” and its services have expanded to include all Armed Forces sectors, with a separate budget, as from the fiscal year of 1394 AH / 1395 AH.

Sponsors